3 February 2025
ANANDA PHARMA PLC
("Ananda" or the "Company")
Change of Registered Office
Ananda (AQSE: ANA), a Company focused on the development of cannabinoid therapies for the treatment of a range of complex conditions, announces that it has moved its registered office to c/o Arch Law Limited, Huckletree Bishopsgate, 8 Bishopsgate, London, EC2N 4BQ.
-Ends-
The Directors of the Company accept responsibility for the contents of this announcement.
For further information, please contact:
|
ANANDA DEVELOPMENTS PLC |
+44 (0)7463 686 497 |
|
|
ir@anandadevelopments.com |
|
Chief Executive Officer |
|
|
Melissa Sturgess |
|
|
|
|
|
Finance Director |
|
|
Jeremy Sturgess-Smith |
|
|
|
|
|
SP ANGEL CORPORATE FINANCE LLP |
+44 (0)20 3470 0470 |
|
|
|
|
Corporate Finance |
|
|
Richard Morrison |
|
|
Caroline Rowe |
|
|
|
|
|
Corporate Broking |
|
|
Abigail Wayne |
|
|
Rob Rees
|
|
|
Yellow Jersey PR (media enquiries) Sarah MacLeod Charles Goodwin Zara McKinlay |
+44 (0)20 3004 9512 ananda@yellowjerseypr.com |
https://investors.anandapharma.co.uk/link/MP704y